Quarterly report pursuant to Section 13 or 15(d)

Income Taxes (Tables)

v3.20.2
Income Taxes (Tables)
9 Months Ended
Jun. 30, 2020
Income Taxes [Abstract]  
Reconciliation of Income Tax Expense (Benefit)



 

 

 

 

 

 

 

 

 

 

 



Three Months Ended

 

Nine Months Ended



June 30,

 

June 30,



2020

 

2019

 

2020

 

2019



 

 

 

 

 

 

 

 

 

 

 

Income tax benefit at U.S. federal statutory rates

$

(584,825)

 

$

(582,652)

 

$

(1,493,179)

 

$

(1,856,337)

State income tax benefit, net of federal benefits

 

(45,268)

 

 

(138,089)

 

 

(115,615)

 

 

(439,952)

Non-deductible expenses

 

332,230 

 

 

2,269 

 

 

335,869 

 

 

7,052 

Effect of foreign income tax rates

 

(16,478)

 

 

43 

 

 

49,908 

 

 

(3,484)

Effect of global intangible low taxed income

 

85,522 

 

 

2,554 

 

 

101,642 

 

 

66,182 

Change in valuation allowance

 

415,449 

 

 

716,442 

 

 

1,097,900 

 

 

2,367,633 

Other, net

 

53,872 

 

 

(1,025)

 

 

54,094 

 

 

(23,887)

Income tax expense (benefit)

$

240,502 

 

$

(458)

 

$

30,619 

 

$

117,207 



Significant Components of Deferred Tax Assets and Liabilities



 

 

 

 

 



June 30,

 

September 30,



2020

 

2019

Deferred tax assets:

 

 

 

 

 

Federal net operating loss carryforwards

$

8,854,855 

 

$

8,971,569 

State net operating loss carryforwards

 

1,686,902 

 

 

1,689,536 

Foreign net operating loss carryforwards – U.K.

 

10,600,648 

 

 

10,486,476 

Foreign capital allowance – U.K.

 

103,400 

 

 

103,400 

Share-based compensation

 

1,116,240 

 

 

804,378 

Interest expense

 

757,141 

 

 

 —

Other, net – U.K.

 

50,781 

 

 

50,781 

Other, net – U.S.

 

592,237 

 

 

434,764 

Gross deferred tax assets

 

23,762,204 

 

 

22,540,904 

Valuation allowance for deferred tax assets

 

(10,928,109)

 

 

(9,830,209)

Net deferred tax assets

 

12,834,095 

 

 

12,710,695 

Deferred tax liabilities:

 

 

 

 

 

In-process research and development

 

(4,072,740)

 

 

(4,072,740)

Developed technology

 

(383,092)

 

 

(424,657)

Covenant not-to-compete

 

(53,872)

 

 

(65,993)

Other, net – Malaysia

 

17,251 

 

 

(3,865)

Other, net – U.S.

 

(6,376)

 

 

(6,376)

Net deferred tax liabilities

 

(4,498,829)

 

 

(4,573,631)

Net deferred tax asset

$

8,335,266 

 

$

8,137,064 



Schedule of Deferred Tax Amounts Classified in Balance Sheets



 

 

 

 

 



June 30,

 

September 30,



2020

 

2019



 

 

 

 

 

Deferred tax asset – U.K.

$

8,610,759 

 

$

8,433,669 

Deferred tax asset – Malaysia

 

17,247 

 

 

 —

Total deferred tax asset

$

8,628,006 

 

$

8,433,669 



 

 

 

 

 

Deferred tax liability – U.S.

$

(292,740)

 

$

(292,740)

Deferred tax liability – Malaysia

 

 —

 

 

(3,865)

Total deferred tax liability

$

(292,740)

 

$

(296,605)